Sort by:

select Language:

Roadmap for introduction and roll‐out of Merck rVSV‐ZEBOV Ebola Virus Disease vaccine in African countries

World Health Organization WHO, (2019)

Revised working paper following AVAREF meeting February 2019. WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epidemic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo. WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.

Regional Ebola Preparedness Overview of Needs and Requirements June to December 2019

World Health Organization WHO, (2019)

This document presents a consolidated summary of urgent activities required to advance preparedness, as elaborated in each country's national plan, with a particular focus on Priority 1 countries. It presents the estimated requirements, needs, and gaps for each of the Priority 1 countries and a summary for Priority 2 countries, as aligned for the period of July to December 2019.

Strategic Response Plan for the Ebola Virus Disease Outbreak in the Provinces of North Kivu and Iture (February - July 2019)

Government of the Democratic Republic of the Congo, World Health Organization, (2019)

Since the beginning of December a significant increase in the incidence of new cases has been observed particularly along the corridor towards the large urban center of Butembo (health zones of Butembo and Katwa) and beyond in the zone of Kayna health center located about 150 km from Goma. In addition, active outbreaks have emerged to the north, particularly in the health zones of Komanda and Oicha. The third strategic response plan (SRP-3), which covers February through end July 2019, considers the salient points and recommendations made during the operational review of the implementation of the SRP-2 and other guidance based on lessons learned and risk analysis.

Plan National de Riposte contre l’épidémie de la maladie à virus Ebola dans les provinces du Nord Kivu et de l'Ituri - République Démocratique du Congo (février – juillet 2019)

Government of the Democratic Republic of the Congo, World Health Organization, (2019)

Cependant depuis le début du mois de décembre, une augmentation importante de l’incidence des nouveaux cas est observée particulièrement le long du corridor vers le grand centre urbain de Butembo (zones de santé de Butembo et Katwa) et au-delà dans la zone de santé de Kayna située à environ 150 km de Goma. Par ailleurs, des foyers actifs ont émergé vers le nord notamment dans les zones de santé de Komanda et Oicha.

26 hits